THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483,418 | -28.2% | 56,016 | -13.8% | 0.00% | 0.0% |
| Q2 2023 | $672,854 | -9.7% | 65,010 | -5.3% | 0.00% | 0.0% |
| Q1 2023 | $745,004 | -12.5% | 68,664 | -9.5% | 0.00% | 0.0% |
| Q4 2022 | $851,138 | +12.6% | 75,859 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $756,000 | +10.7% | 74,534 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $683,000 | -2.3% | 75,342 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $699,000 | -20.0% | 73,158 | -7.5% | 0.00% | 0.0% |
| Q4 2021 | $874,000 | +56.6% | 79,054 | +4.8% | 0.00% | 0.0% |
| Q3 2021 | $558,000 | -47.7% | 75,440 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $1,067,000 | -25.7% | 73,457 | +4.4% | 0.00% | -50.0% |
| Q1 2021 | $1,436,000 | +14.5% | 70,341 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,254,000 | +22.0% | 70,553 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $1,028,000 | -29.4% | 69,547 | +0.3% | 0.00% | -33.3% |
| Q2 2020 | $1,456,000 | -15.5% | 69,351 | -7.0% | 0.00% | -25.0% |
| Q1 2020 | $1,723,000 | -3.4% | 74,542 | +8.2% | 0.00% | +33.3% |
| Q4 2019 | $1,784,000 | +32.9% | 68,906 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,342,000 | +20.7% | 68,906 | +1.2% | 0.00% | +50.0% |
| Q2 2019 | $1,112,000 | -26.5% | 68,083 | +2.0% | 0.00% | -33.3% |
| Q1 2019 | $1,513,000 | -12.7% | 66,762 | -1.5% | 0.00% | -25.0% |
| Q4 2018 | $1,734,000 | -19.0% | 67,751 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $2,142,000 | +44.0% | 65,557 | -0.0% | 0.00% | +33.3% |
| Q2 2018 | $1,487,000 | -4.9% | 65,581 | +1.7% | 0.00% | 0.0% |
| Q1 2018 | $1,564,000 | -14.8% | 64,490 | -2.0% | 0.00% | -25.0% |
| Q4 2017 | $1,836,000 | -19.8% | 65,835 | -1.5% | 0.00% | -20.0% |
| Q3 2017 | $2,289,000 | -22.4% | 66,851 | -9.7% | 0.01% | -16.7% |
| Q2 2017 | $2,949,000 | +1.3% | 74,012 | -6.4% | 0.01% | 0.0% |
| Q1 2017 | $2,911,000 | +10.3% | 79,061 | -4.5% | 0.01% | +20.0% |
| Q4 2016 | $2,638,000 | -5.3% | 82,761 | +7.7% | 0.01% | -16.7% |
| Q3 2016 | $2,785,000 | +61.4% | 76,861 | +1.1% | 0.01% | +50.0% |
| Q2 2016 | $1,726,000 | +51.7% | 76,061 | +25.7% | 0.00% | +100.0% |
| Q1 2016 | $1,138,000 | +31.1% | 60,519 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $868,000 | +70.2% | 52,944 | +14.2% | 0.00% | +100.0% |
| Q3 2015 | $510,000 | -15.8% | 46,376 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $606,000 | -18.7% | 46,576 | +8.4% | 0.00% | -50.0% |
| Q1 2015 | $745,000 | +14.4% | 42,966 | -1.6% | 0.00% | 0.0% |
| Q4 2014 | $651,000 | -35.0% | 43,666 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $1,002,000 | -26.8% | 43,480 | +1.3% | 0.00% | -33.3% |
| Q2 2014 | $1,369,000 | – | 42,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |